#361: Protocol Endpoints: A Clear Map to Navigate the Yellow Brick Road and the End of Endpoint-Creep
Chair
Vice President, Pfizer Inc
Anne Cropp has led the strategic planning and clinical development of several compounds in Cardiovascular and Metabolic diseases, Phases 2-4. Anne has led many business process improvements and has led several initiatives across the spectrum of clinical trial planning, design and...
Read More →
Speakers
Senior Partner/President, Trilogy Writing & Consulting, Germany
After receiving her PhD in Developmental Neurobiology, Julia became a medical writer in 1997. In 2002, she co-founded Trilogy Writing & Consulting, a company specialized in medical writing of regulatory documentation. As Senior Partner and CEO, she continues to bring her enthusiasm...
Read More →
Wednesday June 29, 2016 4:00pm - 5:00pm EDT
203AB
Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA
Trk 06: Med Comm-Wrtg-MSL,
Session
- Credit Type ACPE, CME, IACET, RN
- Audience Intermediate
- Featured Topics Clinical Trial Designs
- Interest Area Study Endpoints, Clinical Research, Rare - Orphan Diseases, R&D - Strategic Issues, Medical Writing
- format json
- Interest Area Study Endpoints,Clinical Research,Rare / Orphan Diseases,R&D / Strategic Issues,Medical Writing
- Featured Topics Clinical Trial Designs
- Credit Type ACPE, CME, IACET, RN
- Tags Session